About Us
Welcome to Aomics GmbH, a German-based data science company that provides comprehensive statistical consulting, programming, and bioinformatics services for healthcare projects, with a particular focus on Immuno-Oncology studies. We possess deep expertise in a wide array of Immuno-Oncology research areas, including clinical statistics, transnational medicine and biomarker research, phase I trials and pharmacokinetic/
Established in 2019, Aomics has recently expanded its global reach by establishing a presence in India, further solidifying our commitment to serving clients worldwide. This expansion reinforces our unwavering dedication to providing unparalleled support and expertise, fostering the advancement of Immuno-Oncology research.
As pioneers in the field, we’re more than just a Clinical solution providers– we’re your strategic partner in scientific progress. Join us on this transformative journey where innovation meets compassion, and together, we shape the future of healthcare.
At Aomics GmbH, our expertise lies in the analysis of multi-omics data, Single Cell data, healthcare data, and clinical trial data. We offer cost-effective and comprehensive solutions tailored to the needs of universities, research institutes, pharmaceutical companies, biotechnology firms, and contract research organizations (CROs).
Our team consists of highly skilled professionals, including biostatisticians, statistical programmers, multi-omics/biological data scientists, medical writers, and AI engineers. We possess expertise in programming languages such as SAS, R, Shell, Python, and specialize in automating high-throughput data analysis processes.
Our core service areas encompass CDISC data standardization, statistical programming, data management, regulatory submissions publishing, testing, and validation services. At Aomics, we are dedicated to enhancing our clients’ profitability through our extensive portfolio of solutions and services.
Leadership Team
Dr. Rahul Sharma
Founder & CEO
Dr. Sharma has 15+ years of experience in managing and conducting biological/clinical data analytical projects. Dr. Sharma has published more than 25 research articles in leading peer-reviewed international journals. During his career, Dr. Sharma has played a key role in developing Artificial Intelligence-based computational algorithms. Dr. Sharma trained at the Goethe University, Frankfurt for his PhD in Bioinformatics (DE) and at Uniklinikum Frankfurt (DE) for his post-doctorate research work.
Mr. Stephan Goldenbaum
Chief Sales Officer (CSO)
Mr. Goldenbaum is a seasoned professional with over two decades of invaluable experience in the fields of Life Science, Pharma-Biotech, and Diagnostics. His impressive career has been marked by a relentless commitment to excellence and a strong track record of leadership and business development across diverse global markets, including Europe, the Middle East, and the Asia Pacific region, with companies like QIAGEN, BioMerieux, Eppendorf and during the last 2 years as managing director of SolisBiodyne.
Ms. Sakshi Bharti
Chief Operating Officer (COO)
Ms. Bharti leverages her extensive experience in project management and a background in bioinformatics to drive our startup’s daily operations and strategic growth. With a strong foundation in healthcare data analysis, she ensures our services meet the highest standards. Her role also encompasses forming and nurturing key partnerships, locally and internationally. Currently completing her Ph.D. in Bioinformatics at Goethe University Frankfurt, Ms. Bharti’s innovative thinking and dedication are propelling our startup.
Who We Are
Aomics is dedicated to advancing clinical development with our specialized expertise. We offer comprehensive and cost-effective solutions tailored to meet the distinct needs of universities, research institutes, pharmaceutical companies, biotechnology firms, and contract research organizations (CROs).
Our Mission
“To empower and accelerate clinical development through data-driven insights and innovative solutions. Our mission is to contribute to the discovery and delivery of life-changing therapies, ultimately improving patient outcomes and transforming the future of healthcare.”
Our Vision
“To be a global leader in advancing clinical development through data-driven insights and innovative solutions, driving the delivery of life-changing therapies and transforming healthcare outcomes.”
Our Values
- Respect
- Honesty
- Innovation
- Integrity & Ethics
- Goal oriented
- Environmental responsibility
- Employee growth
- Customer satisfaction
Our Role
“As a clinical development company, your primary role is to facilitate and oversee the entire process of bringing new therapies and medical products to market. This involves managing and coordinating various aspects of clinical trials and research studies”
Our key priority
As a clinical data analysis and biostatistics company, our priority is providing accurate insights for clinical development. We analyze complex data, ensuring integrity, statistical rigor, and regulatory compliance. Through collaboration and advanced techniques, we optimize trials, accelerate therapy development, and improve patient care. Our commitment to scientific excellence, ethical conduct, and valuable results empowers clients to make informed decisions and enhance healthcare outcomes.
What We Do
- Biostatistics consultation
- Statistical programming
- Biological/healthcare data analytics
- Immunoinformatics solution development
- Drug development
- Bioinformatics Software Development
- AI/ML model development
Why Choose Aomics?
Like other pharma partners who trust our services, here are the reasons why our dedicated team and excellent data analytical services are attracting more and more clients each year:
We utilize a comprehensive approach to data analysis, encompassing data cleaning, transformation, statistical modeling, and visualization. Our team of experienced data analysts employs advanced techniques, including machine learning algorithms and statistical modeling, to extract meaningful insights from complex Immuno-oncology datasets. This expertise enables us to identify patterns, trends, and associations within the data, providing valuable insights for clinical trial design, treatment optimization, and personalized medicine strategies.
Our data analysis goes beyond mere data extraction; we transform raw data into actionable insights that can directly impact clinical research and patient care. We collaborate closely with our clients to understand their specific objectives, translating data into personalized recommendations for clinical trial design, treatment selection, and patient monitoring. These insights empower researchers to make informed decisions that optimize treatment outcomes and accelerate the development of novel Immuno-oncology therapies.
Throughout the entire data analysis process, we uphold the highest standards of quality. Our team adheres to rigorous quality control procedures, ensuring the accuracy, precision, and reproducibility of our findings. We utilize validated methodologies and maintain meticulous documentation to substantiate our conclusions. This unwavering commitment to quality ensures that our clients receive reliable and trustworthy data insights that can be confidently incorporated into clinical decision-making.
We value open communication and collaboration with our clients, ensuring their complete satisfaction and active involvement in the data analysis process. We actively listen to their needs and expectations, tailoring our services to their unique requirements and research objectives. This collaborative approach fosters a strong partnership that empowers clients to make informed decisions based on our expert analysis.
Our team possesses extensive experience and a proven track record of success in supporting Immuno-oncology clinical research. We have successfully assisted numerous clients in achieving breakthrough therapies, demonstrating our ability to translate data into tangible outcomes. Our expertise, coupled with our collaborative approach and unwavering commitment to quality, has earned us a reputation as a trusted partner in the advancement of Immuno-oncology research.
Would you like to start a project with us?
Reach out on the given number or write us an email for further queries regarding project requirements